Literature DB >> 18397367

Characterization of PINK1 processing, stability, and subcellular localization.

William Lin1, Un Jung Kang.   

Abstract

Mutations found in PTEN-induced putative kinase 1 (PINK1), a putative mitochondrial serine/threonine kinase of unknown function, have been linked to autosomal recessive Parkinson's disease. It is suggested that mutations can cause a loss of PINK1 kinase activity and eventually lead to mitochondrial dysfunction. In this report, we examined the subcellular localization of PINK1 and the dynamic kinetics of PINK1 processing and degradation. We also identified cytosolic chaperone heat-shock protein 90 (Hsp90) as an interacting protein of PINK1 by PINK1 co-immunoprecipitation. Immunofluorescence of PINK1 protein and mitochondrial isolation show that the precursor form of PINK1 translocates to the mitochondria and is processed into two cleaved forms of PINK1, which in turn localize more to the cytosolic than mitochondrial fraction. The cleavage does not occur and the uncleaved precursor stays associated with the mitochondria when the mitochondrial membrane potential is disrupted. Metabolic labeling analyses show that the PINK1 processing is rapid and the levels of cleaved forms are tightly regulated. Furthermore, cleaved forms of PINK1 are stabilized by Hsp90 interaction as the loss of Hsp90 activity decreases PINK1 level after mitochondrial processing. Lastly, we also find that cleaved forms of PINK1 are degraded by the proteasome, which is uncommon for mitochondrial proteins. Our findings support a dual subcellular localization, implying that PINK1 can reside in the mitochondria and the cytosol. This raises intriguing functional roles that bridge these two cellular compartments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18397367      PMCID: PMC3638740          DOI: 10.1111/j.1471-4159.2008.05398.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  44 in total

Review 1.  Mechanisms of protein import into mitochondria.

Authors:  Kaye N Truscott; Katrin Brandner; Nikolaus Pfanner
Journal:  Curr Biol       Date:  2003-04-15       Impact factor: 10.834

Review 2.  Protein translocation across biological membranes.

Authors:  William Wickner; Randy Schekman
Journal:  Science       Date:  2005-12-02       Impact factor: 47.728

3.  Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP.

Authors:  M Emdadul Haque; Kelly J Thomas; Cheryl D'Souza; Steve Callaghan; Tohru Kitada; Ruth S Slack; Paul Fraser; Mark R Cookson; Anurag Tandon; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-24       Impact factor: 11.205

4.  Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila.

Authors:  Danling Wang; Li Qian; Hui Xiong; Jiandong Liu; Wendi S Neckameyer; Sean Oldham; Kun Xia; Jianzhi Wang; Rolf Bodmer; Zhuohua Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-24       Impact factor: 11.205

5.  Hsp90 functions in the targeting and outer membrane translocation steps of Tom70-mediated mitochondrial import.

Authors:  Anna C Y Fan; Melanie K Bhangoo; Jason C Young
Journal:  J Biol Chem       Date:  2006-09-12       Impact factor: 5.157

6.  Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.

Authors:  Nicole Exner; Bettina Treske; Dominik Paquet; Kira Holmström; Carola Schiesling; Suzana Gispert; Iria Carballo-Carbajal; Daniela Berg; Hans-Hermann Hoepken; Thomas Gasser; Rejko Krüger; Konstanze F Winklhofer; Frank Vogel; Andreas S Reichert; Georg Auburger; Philipp J Kahle; Bettina Schmid; Christian Haass
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

7.  L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.

Authors:  Yasuhiro Moriwaki; Yeon-Jeong Kim; Yukari Ido; Hidemi Misawa; Koichiro Kawashima; Shogo Endo; Ryosuke Takahashi
Journal:  Neurosci Res       Date:  2008-01-21       Impact factor: 3.304

8.  Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.

Authors:  Andreas Weihofen; Beth Ostaszewski; Yasufumi Minami; Dennis J Selkoe
Journal:  Hum Mol Genet       Date:  2007-11-14       Impact factor: 6.150

9.  Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1.

Authors:  Sho Takatori; Genta Ito; Takeshi Iwatsubo
Journal:  Neurosci Lett       Date:  2007-11-26       Impact factor: 3.046

10.  Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.

Authors:  Tohru Kitada; Antonio Pisani; Douglas R Porter; Hiroo Yamaguchi; Anne Tscherter; Giuseppina Martella; Paola Bonsi; Chen Zhang; Emmanuel N Pothos; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

View more
  112 in total

1.  Pink1 kinase and its membrane potential (Deltaψ)-dependent cleavage product both localize to outer mitochondrial membrane by unique targeting mode.

Authors:  Dorothea Becker; Judith Richter; Maja A Tocilescu; Serge Przedborski; Wolfgang Voos
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

2.  PINK1- and Parkin-mediated mitophagy at a glance.

Authors:  Seok Min Jin; Richard J Youle
Journal:  J Cell Sci       Date:  2012-02-15       Impact factor: 5.285

Review 3.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 4.  Function of cytosolic chaperones in Tom70-mediated mitochondrial import.

Authors:  Anna C Y Fan; Jason C Young
Journal:  Protein Pept Lett       Date:  2011-02       Impact factor: 1.890

Review 5.  Mechanisms of mitophagy.

Authors:  Richard J Youle; Derek P Narendra
Journal:  Nat Rev Mol Cell Biol       Date:  2011-01       Impact factor: 94.444

6.  PINK1 stimulates interleukin-1β-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1.

Authors:  Hyun Jung Lee; Sung Hee Jang; Hyeyoung Kim; Joo Heon Yoon; Kwang Chul Chung
Journal:  Cell Mol Life Sci       Date:  2012-05-29       Impact factor: 9.261

7.  PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease.

Authors:  Patricia Martín-Maestro; Ricardo Gargini; George Perry; Jesús Avila; Vega García-Escudero
Journal:  Hum Mol Genet       Date:  2015-12-31       Impact factor: 6.150

Review 8.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

9.  Loss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia.

Authors:  William Lin; Natasha L Wadlington; Linan Chen; Xiaoxi Zhuang; James R Brorson; Un Jung Kang
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

10.  BNIP3 Protein Suppresses PINK1 Kinase Proteolytic Cleavage to Promote Mitophagy.

Authors:  Tongmei Zhang; Liang Xue; Li Li; Chengyuan Tang; Zhengqing Wan; Ruoxi Wang; Jieqiong Tan; Ya Tan; Hailong Han; Runyi Tian; Timothy R Billiar; W Andy Tao; Zhuohua Zhang
Journal:  J Biol Chem       Date:  2016-08-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.